Abstract
Background & aims Previous studies have suggested a potential link between polyunsaturated fatty acid (PUFA) intake and the risk of cholelithiasis. Omega-3 fatty acids, a key subfamily of PUFAs, have been identified in observational studies as playing a role in lipid regulation and potentially serving as a protective factor against cholelithiasis. In this study, we aim to investigate this association further by analyzing data from the 2017-2020 National Health and Nutrition Examination Survey (NHANES) and conducting Mendelian randomization (MR) analyses.
Methods We employed weighted multivariate-adjusted logistic regression analyses to examine the association between PUFAs and cholelithiasis risk using data from NHANES 2017-2020. Additionally, a two-sample Mendelian randomization (MR) study was conducted utilizing pooled data from Genome-Wide Association Studies (GWAS) to establish the causal relationship between PUFAs and cholelithiasis. Following this, we performed two-step MR mediation analyses to investigate the mediating role of plasma lipids in the pathway, focusing on the strongly positive subfamily of PUFAs, Omega-3, in relation to plasma circulating lipids and cholelithiasis.
Results Our observational study in NHANES included 7,527 participants. Weighted multivariate-adjusted logistic regression analyses initially revealed a negative association between PUFAs, their subclasses, and cholelithiasis. However, this association became nonsignificant after adjusting for multiple covariates. In contrast, MR analyses identified a significant negative association between PUFAs (OR=0.75 [95% CI, 0.58∼0.98]) and Omega-3 (OR=0.79 [95% CI, 0.7∼0.9]) and the risk of cholelithiasis. Specifically, Omega-3 was associated with a reduced risk of developing cholelithiasis (OR=0.77 [95% CI, 0.65∼0.91]), possibly due to the upregulation of LDL-C levels (Beta=0.24 [95% CI, 0.1∼0.38]). This upregulation of LDL-C subsequently lowered the risk of cholelithiasis (OR=0.77 [95% CI, 0.65∼0.91]), with the mediating effect of LDL-C accounting for 28% of the overall association.
Conclusions Both cross-sectional observational analyses and Mendelian randomization (MR) analyses demonstrated a negative correlation between polyunsaturated fatty acids (PUFAs) and cholelithiasis. Omega-3 fatty acids seem to play a key role in this association by increasing plasma LDL-C levels, which in turn may help reduce the risk of cholelithiasis.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the National Key Clinical Specialty (General Surgery) of the First Affiliated Hospital of Wenzhou Medical University.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Publicly available summary statistics are obtained from https://gwas.mrcieu.ac.uk/ (IEU open GWAS), https://www.cdc.gov/nchs/nhanes/index.htm (NHANES), https://www.ukbiobank.ac.uk/ (UK biobank), https://csg.sph.umich.edu/willer/public/glgc-lipids2021/ (GLGC) and https://www.finngen.fi/en (FinnGen).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
1. Figure 3, which was missed in the last commit, was added. 2. Author information has been updated.
8. Data availability
Publicly available summary statistics are obtained from https://gwas.mrcieu.ac.uk/ (IEU open GWAS), https://www.cdc.gov/nchs/nhanes/index.htm (NHANES), https://www.ukbiobank.ac.uk/ (UK biobank), https://csg.sph.umich.edu/willer/public/glgc-lipids2021/ (GLGC) and https://www.finngen.fi/en (FinnGen).
